Group 2 Drug Release
Click here to load reader
Transcript of Group 2 Drug Release
Group 2
Julie Hana
Myrna Hana
Alden Klemm
Julie Guglielmo
Nasser Shehade
Tina Altomeh
Tesha Huston
Detrol LA
Extended-release
Cmax = 75% of normal Detrol formula
Cmin = 150% of normal Detrol formula
Smaller range between peaks and troughs
Taken once daily
Glipizide XL
Extended-release
90% at SS vs. conventional release.
Less peak to trough fluctuations
NuvaRing
Etonogestrel
Cmax = 1,716 pg/mL
Tmax = 200.3 hrs
½ life = 29.3 hrs
CL = 3.4 L/hr
Slowly releases in the vagina
Sustained release
NuvaRing continued
Ethinyl Estradiol
Cmax = 34.7 pg/mL
Tmax = 59.3 hrs
½ life = 44.7 hrs
CL = 34.8 hrs
Sustained-release
Sular
½ life = 7-12 hrs
Cmax = 1.3 pg/mL
Tmax = 6-12 hrs
External and internal core. (external is a slower, extended-release)
Nexium
½ life = 19 hrs
Tmax = 1.5 hrs
In the form of enteric coated granules inside a capsule shell.
Shorter ½ life in plasma, longer half life at site of inhibition (PPI)
Delayed-Release
Aldara
½ life = 10x greater in topical form than in the conventional form
Topical cream
Modified-release
Ortho Evra
AUC and Css are higher
Cmax is lower
Delivered over 7 days versus 1 day
Thin-matrix transdermal patch with 3 layers that extend its release
Extended-Release
Enablex
½ life = 13-19 hours
SS achieved in 6 days
Film-coated tablet, with a very low absorption rate
Extended-Release